IBM books roughly 28 percent more software revenue in Q4 than in Q1, and that gap is where your discount lives
Two calendars run against you. IBM fiscal year ends 31 December, and the price increase lands on 1 January. Most buyers only notice the second, because IBM makes sure they notice it. The first is where the money is.
Prepared by Redress Compliance · August 16, 2026 · IBM advisory.
Executive summary
IBM booked $9 billion of software revenue in Q4 2025 against $7.05 billion in Q1 2026, roughly 28 percent more. That is a structural pull forward, and it tells you when discretion exists and when it does not.
The same deal signed in the last ten days of December beats a February signature. Nothing about the estate changes. What changes is whose quota is on fire, and therefore who can approve what.
Two calendars run simultaneously. The fiscal year ending 31 December drives quota, and the price increase landing 1 January gives the field a legitimate reason to demand a December signature. Only one of them is your leverage.
Leverage is not simply "Q4 is best". It stacks three things: how much of the annual number is unbooked, how far your deal sits from the seller quota gap, and whether the approval you need lives above or below the person who wants your deal.
Where the leverage sits, quarter by quarter
Leverage is not evenly distributed and it is not simply that Q4 is best. It is a function of unbooked annual number, the seller's individual gap, and where the approval authority sits.
| Quarter | Condition | What it means for your ask |
|---|---|---|
| Q1, Jan to Mar | Weakest of the year | Escalation paths are slow because managers have twelve months of runway |
| Q2, Apr to Jun | First real read on the annual number | Mid year forecast pressure begins to bite in the final three weeks |
| Q3, Jul to Sep | Good, and underrated | Sellers pull Q4 deals forward to de risk their own year |
| Q4, Oct to Dec | Maximum need | The quarter the compensation is built around, and where discretion concentrates |
A large deal in a strong quarter can attract less discount than a mid sized deal in a weak one. That is the part the simple "sign in Q4" advice misses. What matters is not the absolute size of your deal but its size relative to the gap the seller is trying to close. If your deal is not the one that decides someone's year, its scale buys you nothing, and a smaller deal that closes a specific gap will move further.
The pull forward is visible in IBM own reported numbers
The argument for timing is usually made from anecdote, which makes it easy to discount. IBM publishes the evidence itself. Q4 2025 revenue came in at $19.69 billion, up 12 percent year over year, with software revenue up 14 percent to $9 billion. Q1 2026 software revenue was $7.05 billion. That is roughly 28 percent more software booked in the fourth quarter than in the first, a gap of about $1.95 billion, and it is not a seasonal characteristic of how enterprises buy software. It is a structural pull forward: deals that could have closed in Q1 or Q2 get dragged into Q4 because that is where the compensation sits, and by extension where the discretion sits.
The posture on the other side of the year is equally observable. IBM's CFO Jim Kavanaugh told analysts, in a phrase worth remembering, that he did not think the company had ever raised guidance in a first quarter. That is not a comment about any individual deal, and it tells you precisely how the deal desk behaves in January and February. Nobody spends discount capital to beat a number they were never going to raise. A serious commercial ask opened in week four of Q1 is being made to a machine that is deliberately holding its powder, and no amount of preparation compensates for asking at the wrong moment.
Two calendars therefore run against you simultaneously and they are frequently confused. The fiscal calendar ends 31 December and rolls quota down through every layer of the sales organisation. The price increase calendar lands increases on 1 January and gives the field a legitimised reason to demand your signature in December. Most buyers notice only the second, because IBM ensures they notice it, and they experience the December pressure as a deadline being imposed on them rather than as evidence of a moment when IBM needs the deal more than they do.
What follows is a sequencing discipline rather than a tactic. The objective is to arrive at IBM's moment of maximum need with a fully prepared, legally cleared, board approved deal that requires only a signature and an approval a first line manager cannot give alone. That last clause matters: a deal that can be approved locally does not create escalation, and escalation is what pulls discretion down from the level where it is held. The negotiation itself is worked in the IBM vendor management playbook, the shelfware position in the shelfware playbook, and the wider library in the IBM practice.
- Your agreements decoded into plain English before the auditor interprets them for you
- Renewal exposure modelled across the full term, with the cap to ask for
- A defensible position paper generated in minutes, not weeks
Twelve months to signature
- Separate your renewal calendar from IBM fiscal calendar, because they are different disciplines and confusing them is how buyers negotiate hard in a quarter where nobody at IBM needs the deal.
- Be legally cleared and board approved before the window, so the only outstanding item at IBM moment of need is a signature and an approval.
- Structure the ask so it cannot be approved locally, since a deal a first line manager can sign alone generates no escalation, and escalation is what reaches the discretion.
- Understand your deal against the seller gap, not against your own budget, because a large deal in a strong quarter can move less than a mid sized one that closes a specific number.
- Do not treat the January price increase as the deadline. It is a legitimised reason for the field to press you, and it is the weaker of the two calendars.
- Consider Q3 seriously, since sellers pulling Q4 deals forward to de risk their year create real discretion earlier than most buyers expect.
What IBM reported numbers show
The case for timing does not rest on advisory anecdote. It rests on figures IBM publishes:
Up 14 percent year over year, within total quarterly revenue of $19.69 billion, itself up 12 percent.
Roughly 28 percent below the preceding quarter, which is a structural pull forward rather than a seasonal pattern in enterprise buying.
Alongside that, the CFO position that guidance has never been raised in a first quarter tells you how the deal desk behaves in January and February. Discount capital is not spent to beat a number nobody intended to raise.
The same estate, the same entitlement position, and the same buyer signed in the last ten days of December beats a February signature. Nothing about the technology changed. What changed is whose quota was on fire.
Your first five moves
- Map your renewal date against IBM fiscal calendar and decide which quarter you intend to sign in, rather than letting your own expiry decide it.
- Complete legal, security, and board approval before the window opens, so nothing but signature remains when IBM needs the deal.
- Size the ask so approval must escalate, because a locally approvable deal never reaches the discretion you are trying to access.
- Assess your deal against the seller gap, not your own budget, since relative size decides whether your deal is the one that matters.
- Treat the January price increase as pressure rather than as a deadline. The IBM practice builds the sequencing plan with you.
Frequently asked questions
Does IBM negotiation timing really change the price?
Materially. The same estate, entitlement position, and buyer signed in the last ten days of December produces a better number than an identical deal in February. Nothing about the technology changes; what changes is whose quota is on fire.
What evidence supports that?
IBM own reported figures. Q4 2025 software revenue was $9 billion, up 14 percent year over year, against Q1 2026 software revenue of $7.05 billion. That is roughly 28 percent more booked in Q4, a gap of about $1.95 billion.
Is that just seasonal enterprise buying?
No, it is a structural pull forward. Deals that could close in Q1 or Q2 get dragged into Q4 because that is where the compensation sits, and by extension where the discretion to discount sits.
Why is Q1 the weakest quarter to negotiate?
Because escalation paths are slow when managers have twelve months of runway, and because the deal desk is not spending discount capital early. IBM CFO has said the company has never raised guidance in a first quarter, which tells you how January and February behave.
Is Q4 always the right answer?
Not simply. Leverage stacks three things: how much of the annual number is unbooked, how far your deal sits from the seller individual gap, and whether the approval you need lives above or below the person who wants the deal.
Can a large deal have less leverage than a small one?
Yes. In a strong quarter, a large deal that is not the one deciding anyone year buys little. A mid sized deal in a weak quarter that closes a specific gap can move further, because relative size to the gap matters more than absolute size.
What are the two calendars?
IBM fiscal calendar, which ends 31 December and rolls quota through every layer of the sales organisation, and the price increase calendar, which lands increases on 1 January. Most buyers notice only the second because IBM ensures they do.
Should we fear the January price increase?
Treat it as pressure rather than as a deadline. It gives the field a legitimised reason to demand a December signature, which is useful information about their need rather than a constraint on your timing.
Why does the approval level matter?
Because a deal a first line manager can approve alone generates no escalation, and escalation is what pulls discretion down from the level where it is actually held. Structure the ask so it has to travel upward.
Is Q3 worth considering?
Yes, and it is underrated. Sellers pull Q4 deals forward to de risk their own year, which creates genuine discretion earlier than most buyers expect, without the crowding that late December brings.
The IBM Audit Is the Sales Call: Timing and ILMT Hygiene Decide It
Sub capacity entitlement is conditional on evidence, not on deployment. A missing metric report converts a sub capacity estate into a full capacity bill, and it arrives on the vendor's calendar.